PARP1-targeted alpha therapy enhances target expression by Hasan Babazada, Paul Martorano, Hsiaoju Lee, Shuyao Geng, Vandana Batra, John M. Maris, Daniel A. Pryma, Sarah B. Gitto, Michael D. Farwell

Get full text

[18F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancer by Sarah B. Gitto, Austin R. Pantel, Kara N. Maxwell, Daniel A. Pryma, Michael D. Farwell, Fang Liu, Quy Cao, Sophia R. O’Brien, Amy S. Clark, Payal D. Shah, Elizabeth S. McDonald

Get full text

A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points by Swarbhanu Sarkar, Jonathan M. Pham, Kimberly J. Edwards, Nitika Sharma, Kexiang Xu, A. Paden King, Andres Fernandez del Castillo, Michael D. Farwell, Daniel A. Pryma, Stephen J. Schuster, Mark A. Sellmyer

Get full text